This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Centre National De La Recherche Scientifique. Active years: 2008-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2010
Title: The Innovations of Guillaume Magueur
Introduction
Guillaume Magueur is a notable inventor based in Le Plessis-Robinson, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for malaria. With a total of 2 patents to his name, Magueur's work is recognized for its potential impact on global health.
Latest Patents
Magueur's latest patents focus on derivatives of artemisinin, a compound known for its effectiveness in treating malaria. His first patent details a new artemisinin derivative, which is described by a specific general formula. The second patent also explores artemisinin derivatives and their uses in treating malaria, showcasing his commitment to advancing medical treatments.
Career Highlights
Guillaume Magueur is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His work there has allowed him to delve deeply into the chemistry of artemisinin and its derivatives, contributing to the scientific community's understanding of malaria treatment.
Collaborations
Magueur has collaborated with esteemed colleagues such as Fabienne Grellepois and Jean-Pierre Begue. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the fight against malaria.
Conclusion
Guillaume Magueur's contributions to the field of medicinal chemistry, particularly through his patents on artemisinin derivatives, highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for improving health outcomes in malaria treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
